For research use only. Not for therapeutic Use.
Ceranib-2 (Cat No.:I011546) is indeed a small molecule inhibitor that targets the lipoprotein lipase (LPL) receptor, which is involved in the metabolism of lipids and plays a key role in the regulation of lipid levels in the blood. By inhibiting the activity of the LPL receptor, Ceranib-2 has been shown to reduce the uptake of lipids in adipose tissue and the liver, leading to a decrease in circulating lipid levels. Ceranib-2 has been studied for its potential therapeutic applications in the treatment of various metabolic disorders, such as dyslipidemia and insulin resistance, and has shown promising results in preclinical studies.
| Catalog Number | I011546 |
| CAS Number | 1402830-75-4 |
| Synonyms | 3-[3-(4-methoxyphenyl)-1-oxo-2-propen-1-yl]-4-phenyl-2(1H)-quinolinone |
| Molecular Formula | C24H17NO3 |
| Purity | ≥95% |
| Target | Ceramidases |
| Solubility | Soluble in DMSO |
| Storage | Store at -20°C |
